Structure and in vitro function of human subcutaneous small arteries in mild heart failure

American Journal of Physiology - Cell Physiology

Volumn 274, Issue 5 43-5, 1998, Pages

  Stephens, Nicola ^a   Drinkhill, Mark J ^b   Hall, Alistair S ^b   Ball, Stephen G ^b   Heagerty, Anthony M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Angiotensin converting enzyme inhibitor; Ramipril

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NORADRENALIN; RAMIPRIL;

ADULT; AGED; ARTERY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; HEART INFARCTION; HUMAN; HUMAN TISSUE; MALE; MORPHOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR UPREGULATION; STRUCTURE ACTIVITY RELATION; TENSION;

EID: 0031832629     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1998.274.5.c1298     Document Type: Article

References (44)

1. Aalkjaer, C., A. M. Heagerty, K. K. Petersen, J. D. Swales, and M. J. Mulvany. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ. Res. 61: 181-186, 1987.
2. Aalkjaer, C., E. B. Pedersen, H. Danielsen, O. Fjeldborg, B. Jespersen, T. Kjaer, S. S. Sorensen, and M. J. Mulvany. Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin. Sci. (Lond.) 71: 657-663, 1986.
3. AIRE Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821-828, 1993.
4. Aitken, M., D. Anderson, B. Francis, and J. Hinde. Statistical Modelling in GLIM. Oxford, UK: Clarendon, 1989.
5. Angus, J. A., C. P. Ferrier, K. Sudhir, D. M. Kaye, and G. L. Jennings. Impaired contraction and relaxation in skin resistance arteries from patients with congestive heart failure. Cardiovasc. Res. 27: 204-210, 1993.
6. Cleland, J. G. F., H. J. Dargie, G. P. Hodsman, S. G. Ball, J. I. S. Robertson, J. J. Morton, B. W. East, I. Robertson, G. D. Murray, and G. Gillen. Captopril in heart failure: a double blind controlled trial. Br. Heart J. 52: 530-535, 1984.
7. Clozel, M., H. Kuhn, and F. Hefti. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 16: 532-540, 1990.
8. Cohn, J. N. Abnormalities of peripheral sympathetic nervous system control in congestive heart failure. Circulation 82, Suppl. I: I-59-I-67, 1990.
9. Cooper, A., and A. M. Heagerty. Blood pressure parameters as determinants of small artery structure in human essential hypertension. Clin. Sci. (Lond.) 92: 551-557, 1997.
10. De Luca, N., G. Rosiello, F. Lamenza, B. Riciardelli, R. Marchegiano, M. Volpe, C. Marelli, and B. Trimarco. Reversal of cardiac and large artery structural abnormalities induced by long-term antihypertensive treatment with trandolapril. Am. J. Cardiol. 70: 52D-59D, 1992.
11. Drexler, H., D. Hayoz, T. Munzel, B. Hornig, H. Just, H. R. Brunner, and R. Zelis. Endothelial function in chronic congestive heart failure. Am. J. Cardiol. 69: 1596-1601, 1992.
12. Falloon, B. J., and A. M. Heagerty. In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 24: 16-23, 1994.
13. Falloon, B. J., N. Stephens, J. R. Tulip, and A. M. Heagerty. Comparison of small artery sensitivity and morphology in pressurized and wire-mounted preparations. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H670-H678, 1995.
14. Filliben, J. J. The probability plot correlation coefficient test for normality. Technometrics 17: 111-117, 1975.
15. Fitzpatrick, D., M. G. Nicholls, H. Ikram, and E. A. Espiner. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure. Br. Heart J. 50: 163-169, 1983.
16. Freslon, J. L., F. Pourageaud, D. Lecaque, and J. Secchi. Effects of trandolapril on vascular morphology and function during the established phase of systemic hypertension in the spontaneously hypertensive rat. Am. J. Cardiol. 70: 35D-42D, 1992.
17. Hall, A. S., G. D. Murray, and S. G. Ball. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Lancet 349: 1493-1497, 1997.
18. Hasking, G. J., M. D. Esler, G. L. Jennings, D. Burton, J. A. Johns, and P. I. Korner. Noradrenaline spillover to plasma in congestive heart failure: evidence of increased cardiorenal and total sympathetic nerve activity. Circulation 73: 615-621, 1986.
19. Heagerty, A. M., C. Aalkjaer, S. J. Bund, N. Korsgaard, and M. J. Mulvany. Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension 21: 391-397, 1993.
20. Hirooka, Y., T. Imaizumi, A. Takeshita, S. Ando, and S. Harada. Impaired endothelium-dependent forearm vasodilation to acetylcholine in patients with essential hypertension and effects of captopril (Abstract). Circulation 82, Suppl. III: III-346 1990.
21. Hirooka, Y., A. Takeshita, T. Imaizumi, S. Suzuki, M. Yoshida, S. Ando, and M. Nakamura. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure. Circulation 82: 147-153, 1990.
22. Hoshino, J., T. Sakamaki, T. Nakamura, M. Kobayashi, M. Kato, H. Sakamoto, T. Kurashina, A. Yagi, K. Sato, and Z. Ono. Exaggerated vascular response due to endothelial dysfunction and role of the renin-angiotensin system at early stage of renal hypertension in rats. Circ. Res. 74: 130-138, 1994.
23. Imaizumi, T., A. Takeshita, T. Ashihara, and M. Nakamura. The effects of sublingually administered nitroglycerin on forearm vascular resistance in patients with heart failure and normal subjects. Circulation 72: 747-752, 1985.
24. Jackson, P. C., J. R. Fraser, A. P. Wolinski, and R. P. H. Wilde. The potential of phase and amplitude images in determining the boundary of the left ventricle. Phys. Med. Biol. 29: 1377-1384, 1984.
25. Jennings, G. J., and M. D. Esler. Circulatory regulation at rest and exercise and the functional assessment of patients with congestive heart failure. Circulation 81, Suppl. II: II-5-II-13, 1990.
26. Katz, S. D., L. Biasucci, C. Sabba, J. A. Strom, G. Jondeau, M. Galvao, S. Solomon, S. D. Nikolic, R. Forman, and T. H. LeJemtel. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J. Am. Coll. Cardiol. 19: 918-925, 1992.
27. Katz, S. D., M. Schwarz, J. Yuen, and T. H. LeJemtel. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure: role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 88: 55-61, 1993.
28. Kubo, S. H., T. S. Rector, A. J. Bank, R. E. Williams, and S. M. Heifetz. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84: 1589-1596, 1991.
29. Langer, S. Z. Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32: 337-362, 1980.
30. Leimbach, W. N., G. Wallin, R. G. Victor, P. E. Aylward, G. Sundlof, and A. L. Mark. Direct evidence from intraneuronal recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73: 913-919, 1986.
31. LeJemtel, T. H., C. S. Maskin, D. Lucido, and B. J. Chadwick. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 74: 245-251, 1986.
32. Levine, T. B., G. S. Francis, S. R. Goldsmith, A. Simon, and J. N. Cohn. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure. Am. J. Cardiol. 49: 1659-1666, 1982.
33. Levy, B. I., J. B. Michel, J. L. Salzmann, P. Poitevin, M. Devissaguet, E. Scalbert, and M. E. Safar. Long-term effects of angiotensin-converting enzyme inhibitors on the arterial wall of adult spontaneously hypertensive rats. Am. J. Cardiol. 71: 8E-16E, 1993.
34. Manhem, P. J. O., S. G. Ball, J. J. Morton, G. D. Murray, B. J. Leckie, R. Fraser, and J. I. S. Robertson. A dose-response study of HOE 498, a new non-sulphydryl converting-enzyme inhibitor, on blood pressure, pulse rate, and the renin-angiotensin aldosterone system in normal man. Br. J. Clin. Pharmacol. 20: 27-35, 1985.
35. Mulvany, M. J., and W. Halpern. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41: 19-26, 1977.
36. Packer, M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77: 721-730, 1988.
37. Packer, M. Role of the sympathetic nervous system in chronic heart failure: a historical and philosophical perspective. Circulation 82, Suppl. I: I-1-I-6, 1990.
38. Scalbert, E., B. Levy, P. Desche, M. Devissaguet, and M. E. Safar. Vascular effects of perindopril: from experimental to clinical investigation. J. Cardiovasc. Pharmacol. 18, Suppl. 7: S25-S32, 1981.
39. SOLVD Investigators. Effect of enalapril on survival in patients with reduced ejection fractions and congestive heart failure. N. Engl. J. Med. 325: 293-302, 1991.
40. 2-purinoceptors. J. Vasc. Res. 29: 347-352, 1992.
41. Thomas, J. A., and B. H. Marks. Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 41: 233-243, 1978.
42. Webber, M. A., J. M. Neutel, and D. M. Smith. Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition. Am. Heart J. 123: 1414-1420, 1992.
43. Wenting, G. J., A. J. Man In'T Veld, A. J. Woittiez, F. Boomsma, K. Laird-Meeter, M. L. Simoons, P. G. Hugenholzt, and M. A. D. H. Schalekamp. Effects of captopril in acute and chronic heart failure: correlations with plasma levels of noradrenaline, renin, and aldosterone. Br. Heart J. 49: 65-67, 1983.
44. Winer, B. J. Statistical Principles in Experimental Design (2nd ed.). New York: McGraw-Hill, 1971.